Douglas Ingram
Vermögen: 12 Mio $ am 31.05.2026
Vermögen: 12 Mio $ am 31.05.2026
Douglas S. Ingram bekleidet die Position des President, Chief Executive Officer & Director bei Sarepta Therapeutics, Inc. Er ist außerdem Mitglied des Vorstands der Allergan Foundation und von Relay Therapeutics, Inc. Zuvor war er als Rechtsanwalt bei Gibson, Dunn & Crutcher LLP, als Chief Executive Officer & Director bei Chase Pharmaceuticals Corp. und als Präsident bei Allergan, Inc. tätig. Herr Ingram erwarb einen Bachelor-Abschluss an der Arizona State University und einen Master-Abschluss an der University of Arizona.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.04.2026 | 390.307 ( 0,37 % ) | 7 Mio $ | 31.05.2026 | |
| 15.01.2026 | 59.016 ( 0,04 % ) | 5 Mio $ | 31.05.2026 | |
RELAY THERAPEUTICS, INC. 0,01 % | 09.06.2026 | 25.000 ( 0,01 % ) | 351 250 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Vorstandsvorsitzender | 26.06.2017 |
| RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
Allergan Foundation | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.03.2026 |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Direktor/Vorstandsmitglied | 01.05.2018 |
| SKYE BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 19.01.2018 |
| ENDO INTERNATIONAL PLC | Direktor/Vorstandsmitglied | 06.11.2017 |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Vorstandsvorsitzender | 01.11.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gibson, Dunn & Crutcher, Inc.
Gibson, Dunn & Crutcher, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Finance |
ECC Capital Corp.
ECC Capital Corp. Real Estate Investment TrustsFinance Provides mortgage finance real estate investment trust services | Finance |
Volcom, Inc.
Volcom, Inc. Apparel/FootwearConsumer Non-Durables Manufactures and distributes clothes and accessories | Consumer Non-Durables |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Life Insurance Co.
Pacific Life Insurance Co. Life/Health InsuranceFinance Provides life insurance products, annuities and mutual funds solutions | Finance |
Allergan Foundation | Health Services |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen